Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

BACKGROUND: Hormone receptor-positive, human epidermal growth factor receptor-2-negative (HR+/HER2−) is the most common type of metastatic breast cancer (mBC). While mBC patients generally have poor prognosis with limited progression-free survival (PFS) and overall survival (OS), those with multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L., Ohashi, Erika, Koo, Valerie, Wu, Eric Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676876/
https://www.ncbi.nlm.nih.gov/pubmed/26693096
http://dx.doi.org/10.1186/s40164-015-0023-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676876/
https://www.ncbi.nlm.nih.gov/pubmed/26693096
http://dx.doi.org/10.1186/s40164-015-0023-0

Ejemplares similares